Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) was the target of some unusual options trad...
Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) insider Timothy Rolph sold 12,500 shares of...
Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) insider Timothy Rolph sold 25,000 shares of...
Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) was the target of some unusual options trad...